Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

544 ARTÍCULOS , VIENDO DEL 361 AL 375

Stratification by a polygenic risk score of common variation aids in Alzheimer's disease rare variant discovery

Olayinka O, Farrell JJ, Zhu C, Khurshid Z; Alzheimer's Disease Sequencing Project; Martin ER, Bush WS, Pericak-Vance MA, Wang LS, Schellenberg GD, Haines JL, Lunetta KL, Zhang X, Farrer LA.

Alzheimers Dement. 2026 Aug;22(8):e71710. doi: 10.1002/alz.71710.

Long-term safety and immunogenicity of ABvac40 active immunotherapy in mild cognitive impairment and very mild Alzheimer's disease: Results from AB1601 phase 2 extension study

Pascual-Lucas M, Lacosta AM, Montañés M, Canudas J, Loscos J, Monleón I, Allué JA, Sarasa L, Fandos N, Romero J, Sarasa M, Torres M, Whyms D, Terencio J, Piñol-Ripoll G, Boada M.

Alzheimers Dement. 2026 Aug;22(8):e71746. doi: 10.1002/alz.71746.

Flash VEP-P2 latency delay in Alzheimer's disease and cognitive impairment: a systematic review and meta-analysis

Song S, Li Y, Lin L, Duan L.

Front Neurol. 2026 Aug 10;17:1772949. doi: 10.3389/fneur.2026.1772949. eCollection 2026.

rTMS modulates early AD progression via synergistic brain network reorganization and peripheral biomarker dynamics

Wang T, Guo M, Wu H, Liu S, Ji Y, Wang P, Xu G.

Geroscience. 2026 Jun;48(3):4295-4311. doi: 10.1007/s11357-025-01888-z. Epub 2025 Sep 27.

The tau biomarker cascade is condensed in Down syndrome compared with sporadic Alzheimer's disease

Zammit MD, Bruzzone H, Cody KA, Morse J, Wilson R, Bettcher BT, McLachlan MJ, McVea AK, DiFilippo AH, Carey FJ, Janelidze S, Hansson O, Price JC, Laymon CM, Minhas DS, Luo W, Rosas HD, Lai F, Lee JH, Lao PJ, Ances BM, Krinsky-McHale SJ, Hom CL, Hartley SL, Zaman SH, Johnson SC, Cohen AD, Head E, Mapstone ME, Handen BL, Christian BT, Tudorascu DL, Langhough RE, Betthauser TJ; Alzheimer Biomarker Consortium–Down Syndrome.

Brain. 2026 Jul 7;149(7):2449-2462. doi: 10.1093/brain/awaf428.

The role of olfactory and salivary gland pathways in periodontal disease-mediated Alzheimer's disease progression: mechanistic insights and early diagnostic implications

Liang H, Yu W, Han Z, Xu B, Zhuang Z, Liu J.

Acta Clin Belg. 2026 Aug;81(4):330-346. doi: 10.1080/17843286.2026.2652268. Epub 2026 Apr 4.

Multi-ancestry studies in multi-omics of Alzheimer's disease: Recent insights and future directions

Shir D, Seifar F, Ertekin-Taner N.

Curr Opin Neurobiol. 2026 Aug;99:103205. doi: 10.1016/j.conb.2026.103205. Epub 2026 Apr 24.

Update on the current state of speech and language testing in Alzheimer's disease

Dhareshwar S, Kane M, Lewis C, Mineur R, Yao K, Snyder PJ, Alber J, Robb C, Lim YY, Vogel AP.

J Alzheimers Dis. 2026 Jul;112(1):5-19. doi: 10.1177/13872877261446637. Epub 2026 May 4.

Associations of plasma biomarkers with age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindred

Malotaux V, Ku V, Ospina Lopera P, Su Y, Chen Y, Singh A, Ruiz-Triviño J, Hidalgo MJ, Osorio L, Serna L, Giraldo D, Alzate D, He B, Tristão-Pereira C, Ramirez Gomez L, Do Carmo S, Cuello AC, Ashton NJ, Reiman EM, Aguillón D, Quiroz YT.

J Prev Alzheimers Dis. 2026 Jun;13(6):100578. doi: 10.1016/j.tjpad.2026.100578. Epub 2026 May 5.

Proteomic comparison of human neural cell-derived extracellular vesicles and parental cells from Alzheimer's disease and cognitively normal individuals

Xin JY, Liu J, Dong HM, Yu HL, Xiao ZS, Hu JN, Jiang Q, Zhu YP, Feng L, Feng Y, Jia YJ, Yuan ZY, Yu ZY, Shi AY, Zeng GH, Wang J, Wang WY, Cheng L, Vella LJ, Li FZ, Masters CL, Wang YJ.

Sci China Life Sci. 2026 Aug;69(8):2772-2787. doi: 10.1007/s11427-025-3243-2. Epub 2026 Apr 30.

The gut-brain axis in Alzheimer's and Parkinson's diseases: a systematic review of microbiota-derived biomarkers and novel therapeutic approaches

Singh VK, Gupta P, Jain SK, Matreja PS.

J Clin Exp Neuropsychol. 2026 Aug;48(6):606-621. doi: 10.1080/13803395.2026.2673084. Epub 2026 Jun 2.

Omics-driven strategies for identifying biomarkers in Alzheimer's disease

Khan Y, Rekha A, Ballal S, Maharana L, Maqbool M, Goyal K, Mishra R, Uniyal P, Alam P, Aljarba TM, Gupta G, Hussain MS.

Metab Brain Dis. 2026 Jun 6;41(1):128. doi: 10.1007/s11011-026-01873-1.

The role of YKL-40 in Alzheimer's disease pathology and drug targeting

Sha Y, Fu H, Lu K, Wang G, Wang Y.

PeerJ. 2026 Jun 8;14:e21361. doi: 10.7717/peerj.21361. eCollection 2026.

Contributions of the Alzheimer's Disease Neuroimaging Initiative to advancing AD research: a targeted review of recent publications

Veitch DP, Miller MJ, Kanoria S, Aisen PS, Beckett LA, Green RC, Harvey DJ, Jack CR Jr, Jagust W, Lee EB, Nho K, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Mindt MR, Saykin AJ, Shaw LM, Toga AW, Tosun D, Landau SM, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2026 Jun;22(6):e71566. doi: 10.1002/alz.71566.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias